NovaBay Pharmaceuticals Inc
NBY1.820USD
-0.120-6.19%
收盘 09/19, 16:00（美东）报价延迟15分钟
10.59M总市值
4.57市盈率 TTM
关于 NovaBay Pharmaceuticals Inc 公司
NovaBay Pharmaceuticals, Inc. 从事伤口护理产品业务。该公司通过其 NeutroPhase 和 PhaseOne 品牌产品为伤口护理市场生产和销售其专有形式的次氯酸。NeutroPhase 和 PhaseOne 用于外科手术中的清洁和冲洗，以及治疗伤口、烧伤、溃疡和其他损伤。
公司简介
公司代码NBY
公司名称NovaBay Pharmaceuticals Inc
上市日期Oct 26, 2007
CEOMr. David E. Lazar
员工数量14
证券类型Ordinary Share
年结日Oct 26
公司地址2000 Powell St Ste 1150
城市EMERYVILLE
上市交易所NYSE American Consolidated
国家United States of America
邮编94608-1804
电话15108998800
网址https://novabay.com/
公司代码NBY
上市日期Oct 26, 2007
CEOMr. David E. Lazar
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Justin M. Hall, Esq.
Mr. Justin M. Hall, Esq.
Vice President - Business Development, General Counsel, Corporate Secretary
Vice President - Business Development, General Counsel, Corporate Secretary
580.00
-0.34%
Mr. Mijia (Bob) Wu
Mr. Mijia (Bob) Wu
Director
Director
122.00
--
Ms. Swan Sit
Ms. Swan Sit
Independent Director
Independent Director
92.00
--
Mr. Yongxiang (Sean) Zheng
Mr. Yongxiang (Sean) Zheng
Director
Director
50.00
--
Ms. Julie Garlikov
Ms. Julie Garlikov
Independent Director
Independent Director
50.00
--
Mr. Tommy Law
Mr. Tommy Law
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
26.00
--
Mr. Paul E. Freiman, Ph.D.
Mr. Paul E. Freiman, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Yenyou (Jeff) Zheng, Ph.D.
Dr. Yenyou (Jeff) Zheng, Ph.D.
Independent Director
Independent Director
--
--
Capt. Jody Cain
Capt. Jody Cain
IR Contact Officer
IR Contact Officer
--
--
Mr. David E. Lazar
Mr. David E. Lazar
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Justin M. Hall, Esq.
Mr. Justin M. Hall, Esq.
Vice President - Business Development, General Counsel, Corporate Secretary
Vice President - Business Development, General Counsel, Corporate Secretary
580.00
-0.34%
Mr. Mijia (Bob) Wu
Mr. Mijia (Bob) Wu
Director
Director
122.00
--
Ms. Swan Sit
Ms. Swan Sit
Independent Director
Independent Director
92.00
--
Mr. Yongxiang (Sean) Zheng
Mr. Yongxiang (Sean) Zheng
Director
Director
50.00
--
Ms. Julie Garlikov
Ms. Julie Garlikov
Independent Director
Independent Director
50.00
--
Mr. Tommy Law
Mr. Tommy Law
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
26.00
--
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
业务USD
名称
营收
占比
Avenova
8.67M
88.67%
Other products
1.07M
10.98%
Other revenue, net
34.00K
0.35%
NeutroPhase
0.00
0.00%
地区USD
名称
营收
占比
United States
9.78M
100.00%
业务
地区
业务USD
名称
营收
占比
Avenova
8.67M
88.67%
Other products
1.07M
10.98%
Other revenue, net
34.00K
0.35%
NeutroPhase
0.00
0.00%
股东统计
更新时间: 8月19日 周二
更新时间: 8月19日 周二
持股股东
股东类型
持股股东
持股股东
占比
Poplar Point Capital Management LLC
17.52%
C2C Wealth Management, LLC
1.68%
Geode Capital Management, L.L.C.
0.58%
Rangeley Capital LLC
0.57%
Two Sigma Investments, LP
0.42%
其他
79.23%
持股股东
持股股东
占比
Poplar Point Capital Management LLC
17.52%
C2C Wealth Management, LLC
1.68%
Geode Capital Management, L.L.C.
0.58%
Rangeley Capital LLC
0.57%
Two Sigma Investments, LP
0.42%
其他
79.23%
股东类型
持股股东
占比
Hedge Fund
18.60%
Investment Advisor
1.75%
Investment Advisor/Hedge Fund
0.58%
Venture Capital
0.35%
Individual Investor
0.02%
其他
78.70%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
43
1.43M
24.52%
+210.59K
2025Q1
42
1.34M
22.96%
+376.59K
2024Q4
40
546.91K
11.19%
+390.20K
2024Q3
42
126.44K
2.60%
+79.02K
2024Q2
44
12.01K
0.89%
-33.08K
2024Q1
44
12.73K
1.48%
-22.10K
2023Q4
45
34.29K
18.48%
+25.73K
2023Q3
47
15.18K
15.11%
-444.00
2023Q2
47
9.53K
10.53%
-5.30K
2023Q1
51
13.02K
22.50%
-2.13K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Poplar Point Capital Management LLC
1.02M
17.54%
+19.91K
+1.99%
Jun 03, 2025
C2C Wealth Management, LLC
55.00K
0.95%
+4.10K
+8.05%
Mar 31, 2025
Geode Capital Management, L.L.C.
35.00K
0.6%
+1.97K
+5.95%
Mar 31, 2025
Two Sigma Investments, LP
17.47K
0.3%
-13.94K
-44.37%
Mar 31, 2025
XTX Markets LLC
19.85K
0.34%
+3.71K
+22.98%
Mar 31, 2025
Tower Research Capital LLC
5.46K
0.09%
+6.00
+0.11%
Mar 31, 2025
UBS Financial Services, Inc.
749.00
0.01%
+749.00
--
Mar 31, 2025
Hall (Justin M)
580.00
0.01%
-2.00
-0.34%
Mar 18, 2025
The Vanguard Group, Inc.
392.00
0.01%
--
--
May 31, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Apr 18, 2024
Merger
35→1
Apr 18, 2024
Merger
35→1
Apr 18, 2024
Merger
35→1
Apr 18, 2024
Merger
35→1
Nov 14, 2022
Merger
35→1
Nov 14, 2022
Merger
35→1
公告日期
类型
比率
Apr 18, 2024
Merger
35→1
Apr 18, 2024
Merger
35→1
Apr 18, 2024
Merger
35→1
Apr 18, 2024
Merger
35→1
Nov 14, 2022
Merger
35→1
Nov 14, 2022
Merger
35→1
Nov 14, 2022
Merger
35→1
Nov 14, 2022
Merger
35→1
